▼ SELL
10b5-1 Plan
$ Value
$54K
Shares
700
Price
$77
Filed
May 13
Insider
Name
Shanmugam Muthusamy
Title
HEAD OF R&D, COO-NOVITIUM OPS
CIK
0001870913
Roles
Director
Officer
Transaction Details
Transaction Date
2025-05-09
Code
S
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
631,920
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024. | The shares were sold in multiple trades at prices ranging from $76.11 to $76.95. The price reported above reflects the weighted average sales price. | The reporting person holds voting and dispositive power over the shares held by Esjay LLC. | The reporting person holds voting and dispositive power over the shares held by SS Pharma LLC.
Filing Info
Shanmugam Muthusamy's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-26 | ANIP | A | $858K |
| 2026-02-11 | ANIP | F | $221K |
| 2025-08-21 | ANIP | ▼ | $4.8M |
| 2025-08-20 | ANIP | ▼ | $4.2M |
| 2025-08-15 | ANIP | ▼ | $4.6M |
| 2025-08-14 | ANIP | ▼ | $4.2M |
| 2025-05-09 | ANIP | ▼ | $54K |
Other Insiders at ANIP (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
|
— | $357K | 2026-03-11 |
|
CAREY STEPHEN P.
SVP & CFO
|
— | $552K | 2026-03-07 |
| Walsh Patrick D | — | $445K | 2026-03-03 |
|
Lalwani Nikhil
PRESIDENT & CEO
|
— | — | 2026-03-07 |
|
Gutwerg Ori
SVP, GENERICS
|
— | $158K | 2026-03-07 |
|
Mutz Christopher
HEAD OF RARE DISEASE
|
— | $1.6M | 2026-03-13 |
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
|
— | — | 2026-02-26 |
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
|
— | — | 2026-02-28 |
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
|
— | $114K | 2026-04-13 |
|
Davis Krista
SVP, CHIEF HR OFFICER
|
— | $785K | 2026-03-09 |